95-24594. Analysis of Adverse Reactions to Monosodium Glutamate (MSG); Availability

[Federal Register Volume 60, Number 191 (Tuesday, October 3, 1995)]
[Notices]
[Page 51803]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-24594]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food And Drug Administration
[Docket No. 92N-0391]


Analysis of Adverse Reactions to Monosodium Glutamate (MSG); 
Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
availability of a document entitled ``Analysis of Adverse Reactions to 
Monosodium Glutamate (MSG),'' which the Life Sciences Research Office 
(LSRO) of the Federation of American Societies for Experimental Biology 
(FASEB) has prepared under a contract with FDA. As announced in the 
Federal Register of December 4, 1992, the agency requested that LSRO/
FASEB undertake a reexamination of scientific data on possible adverse 
reactions to MSG.

ADDRESSES: ``Analysis of Adverse Reactions to Monosodium Glutamate 
(MSG)'' may be ordered from the Life Sciences Research Office, 
Federation of American Societies for Experimental Biology, 9650 
Rockville Pike, Bethesda, MD 20814. The cost of a single paper copy is 
$50. Payment may be made by check or money order. For telephone orders 
or further information on placing an order, call LSRO/FASEB at 301-530-
7030.

FOR FURTHER INFORMATION CONTACT: Lawrence J. Lin, Center for Food 
Safety and Applied Nutrition (HFS-206), Food and Drug Administration, 
200 C St. SW., Washington, DC 20204, 202-418-3103.

SUPPLEMENTARY INFORMATION: In the Federal Register of December 4, 1992 
(57 FR 57467), FDA announced that it had requested that LSRO/FASEB 
undertake a reexamination of scientific data on possible adverse 
reactions to MSG, under a contract (223-92-2185) with FDA. The 
announcement also solicited data and information and advised that there 
would be an open meeting, which was held on April 7 and 8, 1993, for 
public oral presentation of scientific data, information, and views. 
LSRO/FASEB completed this review and submitted to FDA a final report 
entitled ``Analysis of Adverse Reactions to Monosodium Glutamate 
(MSG)''. The agency is now announcing the availability of this final 
report.

    Dated: September 25, 1995.
William B. Schultz,
Deputy Commissioner for Policy.
[FR Doc. 95-24594 Filed 10-02-95; 8:45 am]
BILLING CODE 4160-01-F